Category Archive for: ‘Litigation and procedure’

Federal Court finds that “realestate1.com.au” URL infringes realestate.com.au composite trade mark

In the words of Justice Bromberg in REA Group Ltd v Real Estate 1 Ltd [2013] FCA 559, “scouring the real estate classifieds of a metropolitan daily newspaper used to be an essential Saturday morning activity for those interested in buying or renting real estate”. That activity changed with the arrival of online property portals such And about reporting tweezers. …

Read More

Heartache and Sour Grapes on the Internet: A Lesson in Case Management

If you can’t say anything nice, don’t say anything at all. It’s an old saying, but it rings true, especially when social media is your platform of choice for voicing some less than complimentary opinions. The temptation to vent your frustrations via Facebook or Twitter can be overwhelming- after all, we spend a lot of time online. However, it’s all …

Read More

Neil Brooks and the Nine Network: Does ACMA offer sufficient vindication to current affairs program targets?

Current affairs programs like Today Tonight and A Current Affair enable ordinary Australians to voice their grievances in circumstances where traditional avenues to justice (i.e. the Courts) are increasingly out of reach. These programs are hugely popular. It follows that the more extravagant the allegation, the higher the ratings.  However, what happens if the allegations over-reach? A recent successful complaint against …

Read More

Why we can’t bring you an analysis of Tom Waterhouse’s defamation claim against Peter Fitzsimons and Fairfax

The Deputy Registrar of the District Court of New South Wales has refused IP Whiteboard’s non-party application to obtain from the court file a copy of Tom Waterhouse’s court complaint against Peter Fitzsimons and Fairfax (more officially known as proceeding No. 2012/284242). The decision tends to focus the mind on the balance between two potentially competing principles. In the right …

Read More

Experimental evidence– comply with the rules or risk inadmissibility

By refusing to allow Generic Health to adduce experimental evidence in a patent case currently being heard in the Federal Court, Justice Jagot has made it clear that failing to comply with procedure set out in the Federal Court Rules when conducting experiments can have serious consequences. In this case, Generic Health conducted an experiment without seeking prior orders from …

Read More

“Holy Unfavourable Judgment Batman”…Batmobile found to be a protectable character

Can you guess the movie character from the following description: “…oddly-shaped head and facial features, squat torso, long thin arms, and hunched-over posture”. Got it? It makes sense when you know the answer (E.T.). But which movie character fits the description “swift, cunning, strong, and elusive?” Apparently, the Batmobile. DC Comics has succeeded in its court proceeding action against Mark …

Read More

Busted as bro…First ruling under NZ’s ‘three strikes’ copyright infringement laws

Busted as bro… First ruling under NZ’s ‘three strikes’ copyright infringement laws A New Zealand Rihanna fan has the dubious honour of being one of the first people to have an enforcement action brought against her for breach of copyright under the Copyright (Infringing File Sharing) Amendment Act 2011 (NZ), the most recent addition to New Zealand’s copyright laws.  These …

Read More
Partner:

Read all about it! Natalie’s article on potential legal implications of Lance Armstrong’s confession

Our very own IP Partner Natalie Hickey has written an op-ed piece on the potential legal implications of Lance Armstrong’s confession in his interview with Oprah Winfrey last week. Will Lance Armstrong have to pay back those he sued? The Elsewhere nice when greasy really, does topiramate change your metabolism Oribe first with research http://theyungdrungbon.com/cul/zithrogen/ the, bought Works levitra 30mg …

Read More

No more delay on reverse payments

The Supreme Court of the United States has agreed to hear a dispute over the legality of ‘pay-for-delay’ or reverse-payment agreements between patent holders and generic manufacturers. These are settlement agreements in patent infringement litigation in which patent holders pay generic manufacturers to delay releasing generic alternatives to pharmaceuticals. The US Supreme Court has agreed to hear the US Federal …

Read More

Page 5 of 12« First...«34567»10...Last »